Peer-reviewed Publications
Back to: Experimental Arthritis Treatment Centre for Children
central-page
Most Recent Publications
Back to: Experimental Arthritis Treatment Centre for Children
Natoli, V., Charras, A., Hahn, G. et al. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE). Mol Cell Pediatr 10, 5 (2023). https://doi.org/10.1186/s40348-023-00161-7
Smith EMD, Lythgoe H, Hedrich CM. Current views on lupus in children Curr Opin Rheumatol. 2023 Mar 1;35(2):68-81. doi: 10.1097/BOR.0000000000000913. Epub 2022 Oct 25. PMID: 36286724.
Smith EMD, Aggarwal A, Ainsworth J, Al-Abadi E, Avcin T, Bortey L, Burnham J, Ciurtin C, Hedrich CM, Kamphuis S, Levy DM, Lewandowski LB, Maxwell N, Morand EF, Ozen S, Pain CE, Ravelli A, Saad Magalhaes C, Pilkington CA, Schonenberg-Meinema D, Scott C, Tullus K, Beresford MW; cSLE T2T International Task Force. Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. Ann Rheum Dis. 2023 Jun;82(6):788-798. doi: 10.1136/ard-2022-223328. Epub 2023 Jan 10. PMID: 36627168; PMCID: PMC10314055.
Smith EMD, Egbivwie N, Jorgensen AL, Ciurtin C, Al-Abadi E, Armon K, Bailey K, Brennan M, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, Malik G, McLaren Z, Pilkington C, Ramanan AV, Rangaraj S, Ratcliffe A, Riley P, Sen E, Sridhar A, Wilkinson N, Wood F, Beresford MW, Hedrich CM. Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study Clin Immunol. 2022 Jun;239:109028. doi: 10.1016/j.clim.2022.109028. Epub 2022 May 2. PMID: 35513304.
Lythgoe H, Lj M, Hedrich CM, Aringer M. Classification of systemic lupus erythematosus in children and adults Clin Immunol. 2022 Jan;234:108898. doi:10.1016/j.clim.2021.108898. Epub 2021 Nov 29. PMID: 34856381.
Charras A, Haldenby S, Smith EMD, Egbivwie N, Olohan L, Kenny JG, Schwarz K, Roberts C, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Modgil G, Pilkington C, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Beresford MW, Hedrich CM; UK-JSLE Cohort Study. Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE Rheumatology (Oxford). 2022 May 9:keac275. doi: 10.1093/rheumatology/keac275. Epub ahead of print. PMID: 35532072.
Lythgoe H, Smith EMD, Killeen OG, Murphy R, Pilkington C, Pain CE, Beresford MW; in association with the British Paediatric Surveillance Unit. Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland Rheumatology (Oxford). 2022 Oct 6;61(10):4097-4106. doi:10.1093/rheumatology/keac064. PMID: 35134124.
Smith EMD, Tharmaratnam K, Al-Abadi E, Armon K, Bailey K, Brennan M, Ciurtin C, Gardner-Medwin J, Haslam KE, Hawley D, Leahy A, Leone V, Malik G, McLaren Z, Pilkington C, Ramanan AV, Rangaraj S, Ratcliffe A, Riley P, Sen E, Sridhar A, Wilkinson N, Hedrich CM, Jorgensen A, Beresford MW. Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus Rheumatology (Oxford). 2022 Aug 3;61(8):3378-3389. doi: 10.1093/rheumatology/keab915. PMID: 34894234; PMCID: PMC9348762.
Smith EMD, Lythgoe H, Hedrich CM. Current views on lupus in children. Curr Opin Rheumatol. 2022 Oct 26. doi: 10.1097/BOR.0000000000000913. Epub ahead of print. PMID: 36286724.
Gallagher KL, Patel P, Beresford MW, Smith EMD. What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012? Front Pediatr. 2022 Apr 14;10:884634. doi: 10.3389/fped.2022.884634. PMID: 35498799; PMCID: PMC9047745.
Elliott RS, Taylor E, Ainsworth J, Preston J, Smith EMDS. Improving communication of the concept of 'treat-to target' in childhood lupus: a public and patient (PPI) engagement project involving children and young people. BMC Rheumatol. 2022 Oct 15;6(1):69. doi: 10.1186/s41927-022-00300-z. PMID: 36242078; PMCID: PMC9578343.